Leveraging more than 25 years of experience, Rob provides a wide range of corporate and securities legal services to innovative late-stage and public companies in the life sciences and technology industries. He represents issuers and underwriters in going public transactions, including IPOs, SPACs, reverse mergers, direct listings, as well as in follow-on offerings and private placements of equity and debt securities. Rob also advises boards and management as an outside general counsel on day-to-day corporate and securities matters, including corporate governance, public company reporting, and stock exchange rules and requirements.
Clients praise Rob's "very good technical skill set, terrific work and very up-to-date advice on complex capital markets transactions."
Chambers USA, Client Quote
2020 Edition
Recognition Recognition Recognition
Recognition Recognition Recognition
2020 - 2022
Ranked Rob as a top capital markets lawyer.
2019 - 2021
Named Rob "Lawyer of the Year" in corporate law (2020), and recognized him among “The Best Lawyers in America” for his work in corporate law, and securities and capital markets law (2019 – 2021).
2022
Highlighted among the United States’ leading lawyers for capital markets and healthcare: life sciences work.
2019
Recognized Rob as a Star.